Thymosin Alpha-1
Thymosin Alpha 1 (Ta1) is a naturally occurring 28-amino acid peptide isolated from the thymus. Known for its powerful immune-modulating properties, Ta1 has been used in the treatment of various immune-related disorders, infections, and cancer. It plays a crucial role in restoring and enhancing immune function, making it particularly beneficial for individuals with compromised immune systems or those undergoing cancer therapies.
Ta1 has been widely recognized for its ability to stimulate and support immune responses in conditions like hepatitis B and C, as well as in cancer treatments. Its efficacy in reducing chemotherapy-induced toxicity and boosting vaccine responses further demonstrates its versatility in clinical applications, helping patients with both chronic infections and cancer achieve better outcomes.
By enhancing T cell function and activating immune cells such as NK cells, it is increasingly being explored for its potential in treating a variety of diseases, including autoimmune disorders, viral infections, and cancers. Thymosin Alpha-1 is also valuable in fertility and pregnancy, improving oocyte quality, promoting endometrial receptivity, and reducing oxidative stress, thereby increasing IVF success and improving overall pregnancy rates.
COMPOSITION:
Thymosin Alfa-1 1.6mg
MODE OF ACTION:
Thymosin Alpha 1 (Ta1) boosts immune function by stimulating T cell development and activity, enhancing responses against infections and cancer, especially in compromised individuals. It also activates NK cells and dendritic cells, improving pathogen and tumor cell identification and destruction. Ta1 regulates the immune system, balancing responses in autoimmune diseases and enhancing anti-tumor immunity by modulating inflammation.
Additionally, Ta1 improve cancer treatment outcomes when combined with therapies like chemotherapy and immunotherapy.
Furthermore, Ta1 plays a role in fertility by protecting oocytes and embryos from oxidative damage, improving egg quality and implantation success. It supports oocyte maturation by regulating gonadotropins (FSH and LH), which enhances reproductive outcomes and promotes immune tolerance, reducing the risk of embryo rejection during pregnancy.
INDICATIONS
- Immune enhancer
- Sepsis
- Liver disease (Hepatitis B & C)
- Pancreatitis
- Cancer chemotherapy
- Autoimmune diseases (Rheumatoid Arthritis, Multiple Sclerosis, Lupus)
- Respiratory infections (Lung infection) • Recurrent Implantation Failure(RIF)
Dosage
Prophylaxis:
- 1 vial (1.6 mg)
- Subcutaneous, twice a week for 4 weeks
Mild Symptoms:
- 1 vial (1.6 mg)
- Subcutaneous, once daily for 7 days
Moderate Symptoms:
- 2 vials (3.2 mg)
- Subcutaneous, twice a day (BID) for 7 days
Severe Symptoms:
- 2 vials (3.2 mg)
- Subcutaneous, three times a day (TID) for 7 days
IVF Treatment:
- 1.6 mg to 3.2 mg
- Subcutaneous, 2-3 times a week
- Start a few weeks before IVF or during the stimulation phase
RIF Treatment:
- 1.6 mg
- Subcutaneous, on the first day of menstrual cycle and 48 hours before embryo transfer
- Administer two doses (3.2 mg total)
Disclaimer:
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.
Enquire About Imualfa
Fill the form below and we will get in touch with you